Search company, investor...

Reimbursement Strategies

Founded Year



Acquired | Acquired

About Reimbursement Strategies

Reimbursement Strategies is a Minneapolis-based consultancy focused on reimbursement, health economics and market access for the international life science industry.

Headquarters Location

10287 Lancaster Bay

Saint Paul, Minnesota, 55129,

United States


Missing: Reimbursement Strategies's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Reimbursement Strategies's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Latest Reimbursement Strategies News

AscellaHealth Presents Drug Reimbursement Strategies for 21st Century Cures: IDN & Bio/Pharma Partnering Summit

Aug 10, 2021

August 10, 2021 10:00 AM Eastern Daylight Time BERWYN, Pa.--( BUSINESS WIRE )-- AscellaHealth , a global specialty pharmacy and healthcare solutions company, announces that it will present “Drug Reimbursement Strategies for 21st Century Cures” at the IDN and Bio/Pharma Partnering Summit , Aug. 19, 11:15 a.m.–12 p.m. EDT. The presentation will explore emerging trends in access and reimbursement during this virtual event, which is designed to explore high-impact topics among industry leaders and optimize strategic partnerships to improve access to care and patient outcomes. “With a wave of highly durable and potentially curative therapies in the pipeline for diseases like hemophilia and sickle cell, this session addresses key questions about how to pay for high-cost therapies that promise to be transformative for patients and their families,” says Dea Belazi, president and CEO, AscellaHealth. “The market could soon see a manufacturer charging $5 million to cure a single hemophilia patient based on the lifetime cost savings to the payer. Given this potential, attendees will learn how the current reimbursement system is not designed to handle such large upfront costs for single dose therapies. While the need for alternative payment models is clearly needed, it’s equally important to explore what will become the gold standard for cell and gene therapies.” Moderated by Michael Baldzicki, CRCM, executive vice president, Growth and Strategy, AscellaHealth, the session features Jeffrey Hogan, president, Upside Health Advisors, and Emad Samad, president, Octaviant Financial, Inc., who will explore 1) the use of warranties and pay-overtime models for high-cost therapies, 2) how to maintain a competitive edge in price negotiations and 3) making liabilities for high-cost drugs portable between payers. Belazi adds, “We are looking forward to this important event, which serves as a think-tank for industry pioneers and showcases novel case studies and innovative partnership models that deliver enhanced value, manage costs and improve quality. AscellaHealth is committed to playing a crucial role in helping stakeholders manage drug benefits, lower costs and improve the quality of healthcare.” About AscellaHealth LLC AscellaHealth is a global Specialty Pharmacy and Healthcare services organization serving payers, providers, life sciences and patients, offering a comprehensive portfolio of customized, tech-enabled specialty pharmaceutical and medical management services. AscellaHealth’s unique, patient-centric approach is built upon proprietary technology processes for innovative programs and services optimizing health outcomes and quality of life for patients with complex chronic conditions or rare diseases that require specialty medications and/or gene and cell therapies. Visit . Contacts

Reimbursement Strategies Frequently Asked Questions (FAQ)

  • When was Reimbursement Strategies founded?

    Reimbursement Strategies was founded in 2008.

  • Where is Reimbursement Strategies's headquarters?

    Reimbursement Strategies's headquarters is located at 10287 Lancaster Bay, Saint Paul.

  • What is Reimbursement Strategies's latest funding round?

    Reimbursement Strategies's latest funding round is Acquired.

  • Who are the investors of Reimbursement Strategies?

    Investors of Reimbursement Strategies include NAMSA.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.